Diabetes Devices Market By Type (BGM Devices, Insulin Delivery Devices) By Distribution Channel (Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers Online Pharmacies, Others) By End User (Hospitals, Homecare, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2031. 2024-2035
- PUBLISHED ON
- 1/12/2023
- NO OF PAGES
- 253
- CATEGORY
- Healthcare & Life Sciences
In 2021, the market for Diabetes Devices worldwide was worth $ 24.7 billion US dollars. AMR Group projects that the market will reach US$ 43.4 billion by 2031, growing at a CAGR of 7.8 percent between 2022 and 2031.
Industry Overview
Diabetes is a condition that arises when blood glucose levels exceed normal levels due to a problem with the synthesis of insulin, which regulates glucose levels. Blood glucose, which is obtained from the food eaten, is the main source of energy. Insulin, a hormone produced by the pancreas, controls blood sugar levels. A defect in the body's capacity to create insulin, which prevents it from regulating blood glucose levels, is the cause of diabetes. Normal blood glucose levels vary from 70 to 100 mg/dL, however in diabetes patients, they can go up to 80 to 130 mg/dL. The glucose levels of a diabetic patient are monitored with diabetes care equipment. A continuous glucose monitor (CGM) is a medical gadget that continuously measures and monitors a diabetic patient's blood glucose levels. Those with diabetes may utilize this wearable technology to better control their blood sugar levels, making it very helpful for them. Ketone monitors, blood glucose monitors, continuous glucose monitors, insulin pumps, smart insulin pens, and diabetes management software are a few examples of the various technologies that may track diabetic symptoms. The patient's health is improved by the use of glucose monitoring devices, which assist to maintain and manage glucose levels.
The youth are more likely to get diabetes early due to their younger ages and longer diabetes durations, which lowers their quality of life, reduces life expectancy, and raises healthcare expenditures. As a result, it is anticipated that the incidence of diabetes would rise over time. There is also fear that, as a result of the modern lifestyle and technology improvements, diabetes may be appearing more frequently in children and young people, boosting the usage of diabetes care devices.
Market Dynamics
One of the factors fueling the market's expansion is the rise in diabetes cases brought on by age, obesity, and bad lifestyle choices. Obesity is one of the major causes of diabetes among the people. a rise in diabetes cases with a shift in urbanization and sedentary behavior. The diabetic care market will be dominated during the projected period by technical developments in the field of diabetes devices, an increase in the number of diabetics worldwide, a rise in the need for quick and safe diagnoses, and an increase in diabetes therapies.
Continuous glucose monitoring systems assess blood sugar levels using glucose oxidase. Platinum reacts with glucose oxidase in the sensor to create hydrogen peroxidase, which then generates an electrical signal and transmits it to the transmitter. The sensor is the most important part of equipment used for continuous glucose monitoring. Throughout the projected period, technological developments to increase sensor accuracy are anticipated to fuel market expansion. Nevertheless, blood glucose monitoring systems only provide a range of blood glucose levels rather than a precise measurement of the amount of glucose in the blood. Moreover, negative consequences linked to various diabetes treatment technologies limit market expansion.
COVID Impact
The COVID-19 pandemic gave a positive impact on the Diabetes Devices business market. The COVID-19 global epidemic became a global epidemic, causing significant infection burden and financial issues in several sectors of the global economy. Impact of COVID-19 on the market for diabetic care devices was still favorable compared to other device market. This was because people with various medical conditions, such as diabetes and high blood pressure, were more likely to get this virus. Compared to the general population, diabetes patients had a higher death rate. Diabetes patients need care and constant access to insulin (administered with syringes or pens). As a result, the use of insulin pens and continuous glucose monitoring systems raised the need for careful monitoring and effective diabetes treatment. The COVID-19 pandemic highlighted the need of excellent glycemic management in diabetic patients, in large part because the majority of observational studies have found a link between poorly managed diabetes and an increased risk of hospitalization and viral illness-related death. Population-level real-time continuous glucose monitoring (rtCGM) was utilized to monitor changes in glycemic control with temporal and geographic specificity, according to a research paper by Joost van der Linden et al., published in Diabetes Technologies & Therapeutics Journal in March 2021. Time-in-range (TIR) improvements linked to the COVID-19 epidemic were not uniformly spread across the US.
Regional Trend
Geographically, North America dominated the Diabetes Devices market, accounting with the growth rate of 6.5% of total revenue in 2022. owing to the rising prevalence of diabetes in North America as a result of stress, poor diets, and obesity. By 2027, there will be 34 million diabetes patients in North America, up from the current total of over 29 million. In 2021, there were more than 26 million diabetic patients in only the United States. The market for diabetic care devices in North America is dominated by the United States. The development of the diabetes care device market in this area is also aided by favorable government reimbursement policies and a sophisticated healthcare system. The United States' fast rising incidence and prevalence of diabetic patients, as well as healthcare spending, point to an increase in the use of diabetes care products.
Due to a rise in the prevalence of diabetes there as well as a sizable diabetic and pre-diabetic patient population, an increase in the strengthening of global product manufacturers' distribution networks, and a surge in the expansion of cutting-edge medical facilities in emerging nations like China and India, Asia-Pacific is anticipated to grow at the fastest rate during the forecast period.
Competitive Landscape
Key players operating in the Diabetes Devices Market includes, Abbott Laboratories, ACON Laboratories, Inc., Arkray, Inc., B Braun Melsungen AG, Bayer AG, Becton, Dickinson and Company, Companion Medical, Dexcom Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson, Lifescan, Inc., Medline Industries, Medtronic PLC, Nipro corporation, Novo Nordisk A/S, Sanofi, Terumo Corporation, Valeritas Holding Inc., and Ypsomed Holdings among others. The cooperation between Abbott, CamDiab, and Ypsomed to create and market an integrated automated insulin delivery (AID) system across European nations was announced in April 2022. The connected, intelligent wearable eliminates the need for guesswork in insulin delivery by continuously monitoring a person's blood sugar levels and automatically adjusting and delivering the right quantity of insulin at the right time.
Key USPs-
The World Health Organization (WHO) estimates that low- and middle-income nations are home to 80% of the world's elderly population. The total number of people 60 and older is projected to reach 2 billion by 2050. As a result, the aforementioned reasons are increasing demand for insulin pumps in settings of at-home care, which is anticipated to develop at an exponential rate.
Market Segmentation
Based upon the Type in the Diabetes Devices market is segmented BGM Devices and Insulin Delivery Devices. The Type segment is dominated by Insulin Delivery with the highest revenue share from this segment in the Diabetes Devices market for 2021. In the worldwide diabetes devices market, insulin delivery devices are the category with the quickest rate of growth, accounting for about 56.9% of the market in 2021. The market has been divided into pens, pumps, syringes, and jet injectors based on the insulin delivery device. In 2021, pens had a greater market share for diabetic devices. Based on the Distribution Channel, the Diabetes Devices market is segmented into Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers Online Pharmacies and Others. Due to strong traffic and product availability, hospital pharmacies accounted for over 54.0% of market penetration in 2021. Inpatient and outpatient pharmacies are the two types of pharmacies that work on a hospital site. The hospital has an inpatient pharmacy that serves the operating rooms, intensive care units, inpatient wards, and special service sections but is only available to authorized staff.
End user segment of Diabetes Devices market is further bifurcated into Hospitals, Homecare and Diagnostic Centers. In 2021, the hospital segment held the biggest market share, with 40.9%. Demand for the category is rising as more diabetic people are being admitted to hospitals. Compared to individuals without diabetes, those with diabetes have a threefold increased risk of being hospitalized.
By Type
· BGM Devices
o Self-Monitoring Devices
§ Blood Glucose Meters
§ Testing Strips
§ Lancets
o Continuous Glucose Monitoring Devices
§ Sensors
§ Transmitters
§ Receiver
· Insulin Delivery Devices
o Pumps
o Pens
o Syringes
o Jet Injectors
By Distribution Channel
· Hospital pharmacies
· Retail Pharmacies
· Diabetes Clinics/Centers
· Online Pharmacies
· Others
By End User
· Hospitals
· Homecare
· Diagnostic Centers
Key Benefits:• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Diabetes Devices market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Diabetes Devices would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Diabetes Devices Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Devices Revenue
1.4 Market Analysis by Type
1.4.1 Global Diabetes Devices Market Size Growth Rate by Type: 2023 VS 2032
1.4.2 Blood Glucose Monitoring (BGM) Devices
1.4.3 Insulin Delivery Devices
1.5 Market by Application
1.5.1 Global Diabetes Devices Market Share by Application: 2023-2032
1.5.2 Hospital
1.5.3 Personal Use
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Diabetes Devices Market
1.8.1 Global Diabetes Devices Market Status and Outlook (2017-2032)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Diabetes Devices Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Diabetes Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Diabetes Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Diabetes Devices Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Diabetes Devices Sales Volume Market Share by Region (2017-2022)
3.2 Global Diabetes Devices Sales Revenue Market Share by Region (2017-2022)
3.3 North America Diabetes Devices Sales Volume
3.3.1 North America Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.3.2 North America Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 East Asia Diabetes Devices Sales Volume
3.4.1 East Asia Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.4.2 East Asia Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Diabetes Devices Sales Volume (2017-2022)
3.5.1 Europe Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.5.2 Europe Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 South Asia Diabetes Devices Sales Volume (2017-2022)
3.6.1 South Asia Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.6.2 South Asia Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Southeast Asia Diabetes Devices Sales Volume (2017-2022)
3.7.1 Southeast Asia Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.7.2 Southeast Asia Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.8 Middle East Diabetes Devices Sales Volume (2017-2022)
3.8.1 Middle East Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.8.2 Middle East Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.9 Africa Diabetes Devices Sales Volume (2017-2022)
3.9.1 Africa Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.9.2 Africa Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.10 Oceania Diabetes Devices Sales Volume (2017-2022)
3.10.1 Oceania Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.10.2 Oceania Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.11 South America Diabetes Devices Sales Volume (2017-2022)
3.11.1 South America Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.11.2 South America Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.12 Rest of the World Diabetes Devices Sales Volume (2017-2022)
3.12.1 Rest of the World Diabetes Devices Sales Volume Growth Rate (2017-2022)
3.12.2 Rest of the World Diabetes Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
4 North America
4.1 North America Diabetes Devices Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Diabetes Devices Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Diabetes Devices Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Diabetes Devices Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Diabetes Devices Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Diabetes Devices Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Diabetes Devices Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Diabetes Devices Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Diabetes Devices Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Diabetes Devices Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Diabetes Devices Sales Volume Market Share by Type (2017-2022)
14.2 Global Diabetes Devices Sales Revenue Market Share by Type (2017-2022)
14.3 Global Diabetes Devices Sales Price by Type (2017-2022)
15 Consumption Analysis by Application
15.1 Global Diabetes Devices Consumption Volume by Application (2017-2022)
15.2 Global Diabetes Devices Consumption Value by Application (2017-2022)
16 Company Profiles and Key Figures in Diabetes Devices Business
16.1 Medtronic
16.1.1 Medtronic Company Profile
16.1.2 Medtronic Diabetes Devices Product Specification
16.1.3 Medtronic Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.2 Sanofi
16.2.1 Sanofi Company Profile
16.2.2 Sanofi Diabetes Devices Product Specification
16.2.3 Sanofi Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.3 Bayer
16.3.1 Bayer Company Profile
16.3.2 Bayer Diabetes Devices Product Specification
16.3.3 Bayer Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.4 Becton
16.4.1 Becton Company Profile
16.4.2 Becton Diabetes Devices Product Specification
16.4.3 Becton Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.5 Dickinson and Company
16.5.1 Dickinson and Company Company Profile
16.5.2 Dickinson and Company Diabetes Devices Product Specification
16.5.3 Dickinson and Company Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.6 Novo Nordisk
16.6.1 Novo Nordisk Company Profile
16.6.2 Novo Nordisk Diabetes Devices Product Specification
16.6.3 Novo Nordisk Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.7 Abbott Laboratories
16.7.1 Abbott Laboratories Company Profile
16.7.2 Abbott Laboratories Diabetes Devices Product Specification
16.7.3 Abbott Laboratories Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.8 Roche
16.8.1 Roche Company Profile
16.8.2 Roche Diabetes Devices Product Specification
16.8.3 Roche Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.9 Lifescan
16.9.1 Lifescan Company Profile
16.9.2 Lifescan Diabetes Devices Product Specification
16.9.3 Lifescan Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.10 B. Braun
16.10.1 B. Braun Company Profile
16.10.2 B. Braun Diabetes Devices Product Specification
16.10.3 B. Braun Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.11 Dexcom
16.11.1 Dexcom Company Profile
16.11.2 Dexcom Diabetes Devices Product Specification
16.11.3 Dexcom Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.12 Ypsomed Holdings
16.12.1 Ypsomed Holdings Company Profile
16.12.2 Ypsomed Holdings Diabetes Devices Product Specification
16.12.3 Ypsomed Holdings Diabetes Devices Production Capacity, Revenue, Price and Gross Margin (2017-2022)
17 Diabetes Devices Manufacturing Cost Analysis
17.1 Diabetes Devices Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Diabetes Devices
17.4 Diabetes Devices Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Diabetes Devices Distributors List
18.3 Diabetes Devices Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Diabetes Devices (2023-2032)
20.2 Global Forecasted Revenue of Diabetes Devices (2023-2032)
20.3 Global Forecasted Price of Diabetes Devices (2017-2032)
20.4 Global Forecasted Production of Diabetes Devices by Region (2023-2032)
20.4.1 North America Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.2 East Asia Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.3 Europe Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.4 South Asia Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.5 Southeast Asia Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.6 Middle East Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.7 Africa Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.8 Oceania Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.9 South America Diabetes Devices Production, Revenue Forecast (2023-2032)
20.4.10 Rest of the World Diabetes Devices Production, Revenue Forecast (2023-2032)
20.5 Forecast by Type and by Application (2023-2032)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2023-2032)
20.5.2 Global Forecasted Consumption of Diabetes Devices by Application (2023-2032)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Diabetes Devices by Country
21.2 East Asia Market Forecasted Consumption of Diabetes Devices by Country
21.3 Europe Market Forecasted Consumption of Diabetes Devices by Countriy
21.4 South Asia Forecasted Consumption of Diabetes Devices by Country
21.5 Southeast Asia Forecasted Consumption of Diabetes Devices by Country
21.6 Middle East Forecasted Consumption of Diabetes Devices by Country
21.7 Africa Forecasted Consumption of Diabetes Devices by Country
21.8 Oceania Forecasted Consumption of Diabetes Devices by Country
21.9 South America Forecasted Consumption of Diabetes Devices by Country
21.10 Rest of the world Forecasted Consumption of Diabetes Devices by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI